ACTIVATION OF CLN1 AND CLN2 G(1) CYCLIN GENE-EXPRESSION BY BCK2

被引:0
|
作者
DICOMO, CJ
CHANG, H
ARNDT, KT
机构
[1] COLD SPRING HARBOR LAB,COLD SPRING HARBOR,NY 11724
[2] SUNY STONY BROOK,GENET PROGRAM,STONY BROOK,NY 11794
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Saccharomyces cerevisiae CLN3 protein, a G(1) cyclin, positively regulates the expression of CLN1 and CLN2, two additional G(1) cyclins whose expression during late G(1) is activated, in part, by the transcription factors SW14 and SW16. We isolated 12 complementation groups of mutants that require CLN3. The members of one of those complementation groups hale mutations in the BCK2 gene. In a wild-type CLN3 genetic background, bck2 mutants have a normal growth rate but have a larger cell size, are more sensitive to cu-factor, and hale a modest defect in the accumulation of CLN1 and CLN2 RNA. In the absence of CLN3, bck2 mutations cause an extremely slow growth rate: the cells accumulate in late G(1) with very low levels of CLN1 and CLN2 RNA. The slow growth rate and long G(1) delay of bck2 cln3 mutants are cured by heterologous expression of CLN2. Moreover, overexpression of BCK2 induces very high levels of CLN1, CLN2, and HCS26 RNAs. The results suggest that BCK2 and CLN3 provide parallel activation pathways for the expression of CLN1 and CLN2 during late G(1).
引用
收藏
页码:1835 / 1846
页数:12
相关论文
共 50 条
  • [41] First in man study of intravitreal tripeptidyl peptidase 1 for CLN2 retinopathy
    James Wawrzynski
    Ana Rodriguez Martinez
    Dorothy Ann Thompson
    Dipak Ram
    Richard Bowman
    Rebecca Whiteley
    Chin Gan
    Louise Harding
    Amanda Mortensen
    Philippa Mills
    Paul Gissen
    Robert H. Henderson
    Eye, 2024, 38 : 1176 - 1182
  • [42] A novel mutation in the CLN1 gene in a patient with juvenile neuronal ceroid lipofuscinosis
    Mazzei, R
    Conforti, FL
    Magariello, A
    Bravaccio, C
    Militerni, R
    Gabriele, AL
    Sampaolo, S
    Patitucci, A
    Di Iorio, G
    Muglia, M
    Quattrone, A
    JOURNAL OF NEUROLOGY, 2002, 249 (10) : 1398 - 1400
  • [43] A novel mutation in the CLN1 gene in a patient with juvenile neuronal ceroid lipofuscinosis
    Rosalucia Mazzei
    Francesca L. Conforti
    Angela Magariello
    Carmela Bravaccio
    Roberto Militerni
    Anna L. Gabriele
    Simone Sampaolo
    Alessandra Patitucci
    Giuseppe Di Iorio
    Maria Muglia
    Aldo Quattrone
    Journal of Neurology, 2002, 249 : 1398 - 1400
  • [44] The expression of late infantile neuronal ceroid lipofuscinosis (CLN2) gene product in human brains
    Oka, A
    Kurachi, Y
    Mizuguchi, M
    Hayashi, M
    Takashima, S
    NEUROSCIENCE LETTERS, 1998, 257 (02) : 113 - 115
  • [45] A homogeneous PCR method for rapid detection of the most common mutations in the neuronal ceroid lipofuscinosis genes CLN1 and CLN2.
    Rothberg, PG
    Leman, AR
    Ramirez-Montealegre, D
    Mole, SE
    Pearce, DA
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2005, 7 (05): : 654 - 654
  • [46] Molecular basis of CLN2 disease: A review and classification of TPP1 gene variants reported worldwide
    Mole, Sara E.
    Gardner, Emily
    Schulz, Angela
    Xin, Winnie W.
    MOLECULAR GENETICS AND METABOLISM, 2018, 123 (02) : S97 - S97
  • [47] Brain gene expression profiles of Cln1 and Cln5 deficient mice unravels common molecular pathways underlying neuronal degeneration in NCL diseases
    von Schantz, Carina
    Saharinen, Juha
    Kopra, Outi
    Cooper, Jonathan D.
    Gentile, Massimiliano
    Hovatta, Iiris
    Peltonen, Leena
    Jalanko, Anu
    BMC GENOMICS, 2008, 9 (1)
  • [48] Ethanol fermentation driven by elevated expression of the G1 cyclin gene CLN3 in sake yeast
    Watanabe, Daisuke
    Nogami, Satoru
    Ohya, Yoshikazu
    Kanno, Yoichiro
    Zhou, Yan
    Akao, Takeshi
    Shimoi, Hitoshi
    JOURNAL OF BIOSCIENCE AND BIOENGINEERING, 2011, 112 (06) : 577 - 582
  • [49] Comparison of tripeptidyl peptidase 1 (CLN2) measurement by fluorometry and tandem mass spectrometry
    Lukacs, Zoltan
    Cobos, Paulina Nieves
    Oliva, Petra
    Santer, Rene
    Kasper, David
    MOLECULAR GENETICS AND METABOLISM, 2020, 129 (02) : S103 - S103
  • [50] Brain gene expression profiles of Cln1 and Cln5 deficient mice unravels common molecular pathways underlying neuronal degeneration in NCL diseases
    Carina von Schantz
    Juha Saharinen
    Outi Kopra
    Jonathan D Cooper
    Massimiliano Gentile
    Iiris Hovatta
    Leena Peltonen
    Anu Jalanko
    BMC Genomics, 9